09:25 AM EDT, 06/30/2025 (MT Newswires) -- Tyra Biosciences ( TYRA ) said Monday the first patient has been dosed in a phase 2 study of TYRA-300 in patients with low-grade, intermediate-risk non-muscle invasive bladder cancer. Patients will receive once-daily doses of TYRA-300, with the primary endpoint being complete response at three months. Secondary endpoints include time to recurrence, the...

SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...

June 30 (Reuters) - Aerospace supplier TransDigm Group ( TDG ) said on Monday it will acquire Simmonds Precision Products from defense contractor RTX Corp ( RTX ) for about $765 million in cash. Simmonds makes fuel and proximity sensing and structural health monitoring products for the aerospace and defense industry. Cleveland, Ohio-based TransDigm ( TDG ) supplies aircraft components...

June 30 (Reuters) - Amgen ( AMGN ) said on Monday its experimental cancer therapy significantly improved overall survival in patients with advanced gastric cancer when combined with chemotherapy, marking a potential breakthrough for one of the deadliest cancers. Patients receiving the therapy, bemarituzumab, along with chemotherapy in the late-stage trial lived longer than those who received chemotherapy alone, the...